Literature DB >> 26161056

Temperament and character profiles of patients with chronic idiopathic urticaria.

Sevil Alan1, Fatih Canan2, Ayşe Akman Karakaş1, Nihal Geçici3.   

Abstract

INTRODUCTION: Psychosocial factors have been implicated as being important in the onset and/or exacerbation of urticaria. AIM: To examine both personality factors of patients with chronic idiopathic urticaria (CIU) and the correlations between illness duration, severity of itching, urticaria activity score (UAS) and temperament-character dimensions.
MATERIAL AND METHODS: A total number of 70 CIU patients and 60 healthy individuals were included in the study. The Temperament and Character Inventory (TCI) was administered individually. The relationship between UAS, illness duration and severity of pruritus and TCI subscales were evaluated.
RESULTS: The CIU group had significantly higher scores of novelty seeking and lower scores of cooperativeness, reward dependence and self-directedness than the control group.
CONCLUSIONS: The current study shows that CIU patients have distinctive temperament and character dimensions when compared with the control group. We suggest that evaluation and treatment of CIU should also include psychosomatic approaches in clinical practice.

Entities:  

Keywords:  character; chronic idiopathic urticaria; temperament

Year:  2015        PMID: 26161056      PMCID: PMC4495117          DOI: 10.5114/pdia.2015.48063

Source DB:  PubMed          Journal:  Postepy Dermatol Alergol        ISSN: 1642-395X            Impact factor:   1.837


Introduction

Chronic urticaria (CU) is a polyetiological dermatologic disease [1, 2]. Chronic urticaria can be defined as a daily or almost daily occurrence of temporary and itchy wheals for at least 6 weeks. It remains a major health problem in terms of investigation, aetiology, and management [3]. The etiological reason cannot be found in many cases and the disease is described as chronic idiopathic urticaria (CIU) [4]. Personality traits have been shown to be associated with dermatological disorders [5]. For example, patients with psoriasis, alopecia or urticaria were more hostile and neurotic than people with other dermatological diseases [6]. Psychosocial factors, and personality in particular, play a role in the course and development of CIU as well [7]. Some authors reported that subjects with CIU have significantly interpersonally sensitive, depressive, more hysteric, and suspicious personality traits compared to healthy controls [8]. Until now, few studies have been conducted to investigate the association of personality disorders and psychosomatic disorders with chronic urticaria. However, there is no study that evaluated characteristics of patients with urticaria in terms of temperament and character dimensions. The dimensional psychological approach to the personality model is developed by Cloninger et al. [9] who defined that personality had two primary components: temperament and character. The character is defined as individuals’ relatively objectively, unchanging observed behaviours and subjectively notified inner experiences. Temperament is defined as the aptitude to show an automatic reaction to emotional warnings by being innate structural. It is proclaimed that the components of temperament are genetically independent and show hereditary characteristics by 40% to 60%, and also, it is proclaimed that the genetic effects in character bases are effective by 10% to 15% and the experienced environmental effects by 30% to 35% [9, 10]. According to Cloninger, personality is a result of interaction between environmental and genetic factors [10].

Aim

The aim of this study is to examine the personality and character features of CIU patients and compare them with healthy controls using the temperament and character inventory (TCI). Our second goal was to evaluate the correlations between temperament and character dimensions with clinical factors such as the illness duration and severity of the pruritus and urticaria activity score (UAS) of CIU patients.

Material and methods

Seventy patients with CIU and 60 healthy controls, who were referred to the Akdeniz University Dermatology and Venereology outpatient clinic between June 2013 and September 2013 were included in the study. Eligible patients were 18 to 70 years of age, diagnosed with CIU, literate, did not have any systemic or metabolic diseases, and had no dermatological diseases other than CIU. The exclusion criteria were major depression, dementia, mental retardation, cognitive impairment, recurrent suicidal thoughts, psychotic illness, psychiatric drug-use, advanced neurological diseases, and decompensated systemic diseases. Initially, patients with CIU who presented to our dermatology clinic were informed about the study and were asked whether they agreed to participate. After examination in the dermatology clinic, patients diagnosed with CIU and who chose to participate in the study were assessed, and the following demographics were noted: age, gender, education level, and duration of urticaria. Seventy patients who complied with the criteria were included in the study. For the control group, volunteers who were not diagnosed with urticaria or any systemic, metabolic or psychiatric disorder were included. After recording the sociodemographic characteristics of patients and the control group, the TCI was applied.

Ethical considerations

This study was approved by the ethics committee of the Antalya Education and Research Hospital and conducted according to the ethical standards of the Helsinki Declaration of 2000. All subjects signed written informed consent.

Dermatologic measures

The urticaria activity score (UAS): The UAS was calculated according to the EAACI/GA2LEN/EDF guidelines [3] and as described by the Maurer group [11]. The UAS was estimated according to the number of wheals and pruritus intensity, on the day of blood sampling, applying the following scheme: no wheals = 0, 1–10 wheals = 1, 11–50 wheals = 2, 50 wheals = 3 and pruritus intensity: no = 0, mild = 1, moderate = 2, severe = 3. UAS scores: daily (minimum = 0; maximum = 6). The UAS was classified as follows: 0–2 (mild), 3–4 (moderate) and 5–6 (severe). Visual analogue scale (VAS): A visual analogue scale referring to overall urticaria severity during the preceding 2 weeks was completed by the patient at each follow-up appointment. The scale ranged from 0 to 10, 0 indicating no disease and 10 indicating very severe urticaria [12].

Psychiatric measures

Temperament and Character Inventory (TCI): The TCI has been used extensively in studies relating psychopathology and personality. The TCI was developed by Cloninger et al. [9] and the Turkish version of the TCI has been validated by Köse et al. [13]. It has been commonly used in different areas of psychiatric and psychological research and practice in the last 10 years. This self-reported scale consists of 240 items with “true” or “false” as the response options; it can be applied to individuals aged 18 years old or older. The TCI consists of seven main scales formed by four dimensions of temperament (novelty seeking (NS), harm-avoidance (HA), reward dependence (RD), and persistence (P)) and 3 dimensions of character ((self-directedness (SD), cooperativeness (C) and self-transcendence (ST)), along with 24 subscales of these scales: exploratory excitability (NS1), impulsiveness (NS2), extravagance (NS3), disorderliness (NS4); anticipatory worry (HA1), fear of uncertainty (HA2), shyness with strangers (HA3), fatigability (HA4); sentimentality (RD1), openness to warmth (RD2), attachment (RD3); taking responsibility (SD1), intentionality (SD2), resourcefulness (SD3), self-acceptance (SD4), congruent second nature (SD5); social acceptance (C1), empathy (C2), helpfulness (C3), compassion (C4), virtuousness-scrupulousness (C5); self-loss (ST1), people transpersonal identification (ST2), and spiritual acceptance (ST3).

Statistical analysis

A power analysis demonstrated that 40 patients would be required in each group to detect significant differences in TCI scores with a power of 80% and a level of significance of α = 0.05. Data were computerised using the Statistical Packages for the Social Sciences (SPSS v.18.00; SPSS Inc., Chicago, IL, USA). Both groups were compared in terms of TCI main and sub-scale scores. The Kolmogorov-Smirnov test and Shapiro-Wilk test were used to test the normal distribution of the data. As they were normally distributed, the CIU and control (healthy normal) groups were compared with Students t -test. Mann-Whitney U-test was used because the data were not compatible with normal distribution. As they were normally distributed, the differences in the TCI scores between the CIU patients and control groups were analysed using an Pearson's correlation test and Spearman's nonparametric correlation test were obtained between the UAS, the illness duration and VAS. A p value < 0.05 was considered statistically significant.

Results

The sociodemographic characteristics of patients with CIU and the control group are shown in Table 1. In our study, patients with CIU scored higher on NS (Novelty seeking), NS3 (Extravagance), NS4 (Disorderliness) and spiritual acceptance (ST3) scale/subscales of the TCI than controls (p < 0.05). In addition, the scores in HA2 (Fear of uncertainty), C (Cooperativeness), C1 (Social acceptance), C2 (Empathy), C3 (Helpfulness), C4 (Compassion), C5 (Virtuousness scrupulousness), SD (Self-Directedness), SD1 (Taking responsibility), SD2 (Intentionality), SD5 (Congruent second nature), RD1 (Sentimentality), ST2 (People transpersonal identification) scales/subscales were significantly lower in patients with CIU than in controls (Tables 2, 3). There were no significant differences between patients and healthy volunteers with regard to other scales/subscales of the TCI (p > 0.05). Additionally, the women with CIU had only a lower score on C2 (Empathy) (p = 0.007). There were no significant differences between men and women with CIU with regard to other scales/subscales of the TCI (p > 0.05).
Table 1

Demographic features of patients and control groups

ParameterPatients (n = 70)Controls (n = 60)Value of p
Age, mean ± standard deviation*41.56 ±11.7137.80 ±11.910.111
Gender, n (%)**:0.123
 Female52 (74.3)37 (61.7)
 Male18 (25.7)23 (38.3)
Marital status, n (%):0.724
 Single12 (17.1)16 (26.7)
 Married51 (72.9)41 (68.3)
 Divorced/widowed7 (10.0)3 (5)
Education, n (%)**:0.986
 Primary school36 (51.4)28 (56.8)
 High school18 (25.7)16 (26.6)
 University16 (22.9)16 (26.6)

Student's t-test

χ2 test.

Table 2

Differences between patients and controls with regard to TCI scales

TCI scalesPatients (n = 70)Controls (n = 60)Value of p
Novelty seeking (NS)22.50 ±4.0320.66 ±3.340.008
Harm avoidance (HA)15.34 ±5.1715.98 ±4.230.446
Self-directedness (SD)15.95 ±5.7918.51 ±5.240.001
Cooperativeness (C)10.80 ±4.5215.70 ±4.49< 0.001
Reward dependence (RD)8.90 ±2.539.98 ±1.980.006
Self-transcendence (ST)13.44 ±4.77712.96 ±4.230.552
Persistence (P)2.52 ±1.722.65 ±1.440.668
Table 3

Differences between patients and controls with regard to TCI subscales

TCI subscalesPatients (n = 70)Controls (n = 60)Value of p
Exploratory excitability (NS1)4.84 ±1.624.96 ±1.380.645
Impulsiveness (NS2)6.25 ±1.335.80 ±1.640.083
Extravagance (NS3)4.52 ±1.753.93 ±1.530.044
Disorderliness (NS4)6.87 ±1.765.96 ±1.800.005
Anticipatory worry (HA1)4.10 ±1.974.35 ±1.710.518
Fear of uncertainty (HA2)2.35 ±1.483.03 ±1.500.007
Shyness with strangers (HA3)3.94 ±1.423.56 ±1.480.208
Fatigability (HA4)4.95 ±2.185.03 ±1.700.706
Taking responsibility (SD1)3.75 ±1.794.41 ±1.900.046
Intentionality (SD2)2.41 ±1.533.08 ±1.660.019
Resourcefulness (SD3)1.35 ±1.161.66 ±1.320.159
Self-acceptance (SD4)5.28 ±2.395.41 ±1.890.733
Congruent second nature (SD5)3.14 ±1.713.93 ±1.910.028
Social acceptance (C1)1.61 ±0.162.60 ±1.35< 0.001
Empathy (C2)2.00 ±1.212.50 ±1.210.016
Helpfulness (C3)2.94 ±1.063.78 ±1.30< 0.001
Compassion (C4)1.82 ±1.903.55 ±1.88< 0.001
Virtuousness-scrupulousness (C5)2.42 ±1.193.26 ±1.560.001
Sentimentality (RD1)1.80 ±1.292.65 ±1.28< 0.001
Openness to warmth (RD2)3.62 ±1.463.76 ±1.280.572
Attachment (RD3)3.45 ±1.343.56 ±1.380.649
Self-loss (ST1)4.82 ±2.144.45 ±2.020.305
People transpersonal identification (ST2)3.25 ±1.983.95 ±1.950.048
Spiritual acceptance (ST3)5.34 ±2.064.56 ±1.970.031
Demographic features of patients and control groups Student's t-test χ2 test. Differences between patients and controls with regard to TCI scales Differences between patients and controls with regard to TCI subscales For all patients, the mean duration of the illness was 60.64 ±97.25 months (6–480 months). Urticaria activity score ranged between 0 and 6. The mean UAS score was 3.14 ±1.60. Visual analogue scale ranged was 0–10. The mean VAS score was 7.17 ±2.95. As shown in Table 4, duration of the illness correlated positively with SD (Self-directedness), SD1 (Responsibility), and SD4 (Self-acceptance) subscales. Severity of pruritus correlated negatively with the ST (Self-transcendence) and ST1 (Self-loss) subscales, and positively with the SD1 (Responsibility) subscale. Urticaria activity score correlated positively with RD4 (Dependence) and Reward dependence (RD) subscales.
Table 4

Correlations between TCI scores and duration of disease, itch severity score, and UAS

VariableDuration of the diseaseItch severity score (VAS)UAS
r p r p r p
Responsibility (SD1)0.2540.0340.2480.0380.0760.536
Self-acceptance (SD4)0.2840.0170.1070.3770.0250.843
Self-directedness (SD)0.2450.0410.1330.2720.0620.617
Self-transcendence (ST)0.0400.743–0.2610.0290.0110.910
Self-loss (ST1)0.0390.753–0.2350.0490.0970.305
Reward dependence (RD)0.0470.7050.0980.4220.2690.025
Dependence (RD4)0.2130.0810.0550.5650.2660.026
Correlations between TCI scores and duration of disease, itch severity score, and UAS

Discussion

The aim of this study was to investigate whether the patients with CIU had different personality characteristics than healthy individuals. Patients with CIU were found to score lower on novelty seeking, extravagance and lower on fear of uncertainty, cooperativeness, social acceptance, empathy, helpfulness, compassion, virtuousness-scrupulousness, and self-directedness dimensions of TCI than healthy subjects. An association between psychological factors and CIU have been reported [14]. Chronic idiopathic urticaria is often associated with psychiatric symptoms, such as depression and anxiety, and with stress, which may play a role in the genesis of the disease as well as in its evolution [15]. A high prevalence of mental disorders has been reported in patients with urticaria [16]. Staubach et al. [17] have found that 48% of 111 patients with CU were diagnosed with one or more psychosomatic disorders; most common were anxiety disorders (especially phobias), followed by depressive and somatoform disorders. A similar prevalence rate (49.4%) was found in the study by Uguz et al. [8]. In that study [8], the authors have observed that 44.9% of the patients with CIU had at least one personality disorder and the most common personality disorder was found to be obsessive-compulsive personality disorder (30.3%). The patients with urticaria were found to be less dominant, more intropunitive, more extrapunitive and more neurotic than the healthy control group [6]. A few studies in the literature have used the NEO-Five Factor Inventory [18] which aims to measure the “Big Five” personality traits: neuroticism, extraversion, openness to experience, agreeableness, and conscientiousness in patients with CIU. People with CIU were found to have a significantly higher level of neuroticism [19] and lower level of extraversion [14] than healthy individuals. However, up to now, no studies have used TCI to evaluate personality characteristics of patients with CIU. The personality and character dimensions of patients with dermatological disease is of interest. Kim et al. [20] have shown that the patients with atopic dermatitis were found to score higher on harm avoidance and lower on reward dependence, self-directedness and cooperativeness than the healthy controls. KIlIç et al. [21] have investigated 105 patients with psoriasis and found that the patients had significantly higher scores of harm avoidance and lower scores of being self-directedness than the control group. Reward dependence, persistence, fear of uncertainty, harm avoidance, self-directedness, cooperativeness and self-transcendence scores were found to be significantly higher in hyperhidrosis patients when compared with healthy controls [22]. In our study, patients with CIU were found to score higher on novelty seeking and extravagance dimensions of TCI than healthy subjects. Novelty seeking and extravagance are human personality traits characterized by impulsive, exploratory, or sensation-seeking behaviour. We also found that CIU patients had lower scores on fear of uncertainty dimension and fear of uncertainty is the central psychological motivation underlying conservatism. Moreover, patients with CIU had lower scores on cooperativeness, social acceptance, empathy, helpfulness, compassion, and virtuousness-scrupulousness dimensions. These findings may reveal that patients with CIU have a deficit in social interactions. Personality traits are shown to play a role in the development and progression of medical problems because they have been shown to contribute to the development and progression of health problems [23]. Cloninger's model of personality gives the possibility to establish a connection between functioning of brain systems of interconnected neurons governing behavioural activation, behavioural inhibition, and behavioural maintenance [24]. For example, the temperament dimension of harm avoidance is suggested to indicate central serotonergic turnover [25]. An inverse relationship was found between harm avoidance and serotonin and a positive relationship between self-directedness and serotonin [26]. Moreover, dopamine was shown to be related with novelty seeking [27]. Some neurotransmitters are speculated to play an important role in specific types of urticaria [28]. Two types of urticaria are described according to this view: 1) Adrenergic urticaria, a rare form of stress-induced physical urticaria, caused by various triggers, including emotional upset, coffee, and chocolate, during which serum catecholamines and IgE are elevated, whereas histamine and serotonin levels remain within normal limits [29], 2) Cholinergic urticaria, which is associated with nicotine, acetylcholine, or methacholine [30]. In this respect, neurotransmitter alterations may explain the relationship between personality dimensions and CIU. In this study we found that duration of the disease, urticaria, and pruritus severity and frequency of attacks weak correlated with certain personality traits. Thus our results may contribute to the literature revealing that psychological factors play an important role in the attacks and frequency of exacerbations of urticaria. We believe this study will provide a contribution to further studies in understanding the role of personality characteristics in CIU.

Conclusions

The current study shows that CIU patients have distinctive temperament and character dimensions when compared with the control group. We suggest that evaluation and treatment of CIU should also include psychosomatic approaches in clinical practice.
  27 in total

1.  Guess what! Adrenergic urticaria.

Authors:  B Maerens-Tchokokam; M Vigan; F Breuillard; D A Vuitton; P Girardin; R Laurent
Journal:  Eur J Dermatol       Date:  1999-03       Impact factor: 3.328

2.  The "disease-prone personality". A meta-analytic view of the construct.

Authors:  H S Friedman; S Booth-Kewley
Journal:  Am Psychol       Date:  1987-06

3.  High prevalence of mental disorders and emotional distress in patients with chronic spontaneous urticaria.

Authors:  Petra Staubach; Markus Dechene; Martin Metz; Markus Magerl; Frank Siebenhaar; Karsten Weller; Peter Zezula; Annegret Eckhardt-Henn; Marcus Maurer
Journal:  Acta Derm Venereol       Date:  2011-09       Impact factor: 4.437

Review 4.  Chronic urticaria: pathogenesis and treatment.

Authors:  Allen P Kaplan
Journal:  J Allergy Clin Immunol       Date:  2004-09       Impact factor: 10.793

5.  Hostile personality characteristics, dysthymic states and neurotic symptoms in urticaria, psoriasis and alopecia.

Authors:  G C Lyketsos; J Stratigos; G Tawil; M Psaras; C G Lyketsos
Journal:  Psychother Psychosom       Date:  1985       Impact factor: 17.659

6.  Changes on the Temperament and Character Inventory after paroxetine treatment in volunteers with generalized anxiety disorder.

Authors:  C Allgulander; C R Cloninger; T R Przybeck; L Brandt
Journal:  Psychopharmacol Bull       Date:  1998

7.  Anxiety, depression, psychosomatic symptoms and autonomic nervous function in patients with chronic urticaria.

Authors:  M Hashiro; M Okumura
Journal:  J Dermatol Sci       Date:  1994-10       Impact factor: 4.563

8.  Axis I and Axis II diagnoses in patients with chronic idiopathic urticaria.

Authors:  Faruk Uguz; Burhan Engin; Ertan Yilmaz
Journal:  J Psychosom Res       Date:  2008-02       Impact factor: 3.006

Review 9.  An approach to the patient with urticaria.

Authors:  S J Deacock
Journal:  Clin Exp Immunol       Date:  2008-08       Impact factor: 4.330

10.  The role of focal infections in the pathogenesis of psoriasis and chronic urticaria.

Authors:  Paweł Łukasz Brzewski; Magdalena Spałkowska; Magdalena Podbielska; Joanna Chmielewska; Marta Wołek; Katarzyna Malec; Anna Wojas-Pelc
Journal:  Postepy Dermatol Alergol       Date:  2013-04-12       Impact factor: 1.837

View more
  4 in total

1.  Sense of coherence as a protective factor in chronic urticaria.

Authors:  Alicja Ograczyk; Joanna Miniszewska; Anna Pietrzak; Anna Zalewska-Janowska
Journal:  Postepy Dermatol Alergol       Date:  2017-04-13       Impact factor: 1.837

2.  The role of anxious temperament in patients with allergic rhinitis.

Authors:  Halil Ibrahim Tas; Ozge Caglar
Journal:  Saudi Med J       Date:  2019-01       Impact factor: 1.484

3.  Is There an Association between Restless Legs Syndrome and Urticaria?

Authors:  Serpil Tuna; Sevil Alan; Nehir Samancı; Ayşe Akman Karakaş
Journal:  J Korean Med Sci       Date:  2016-03-29       Impact factor: 2.153

4.  Stress, itch and quality of life in chronic urticaria females.

Authors:  Alicja Ograczyk-Piotrowska; Zofia Gerlicz-Kowalczuk; Anna Pietrzak; Anna M Zalewska-Janowska
Journal:  Postepy Dermatol Alergol       Date:  2018-04-24       Impact factor: 1.837

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.